What is a stock summary page? Click here for an overview.
Business Description
Malin Corporation PLC
ISIN : IE00BVGC3741
Compare
Compare
Traded in other countries / regions
MLC.Ireland0Y71.UKMLLNF.USA IPO Date
2017-01-06Description
Malin Corporation PLC is a life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in the life sciences industry. The company derives all of its revenue from its subsidiary. The company focuses on oncology, immunology, and genetic diseases where it believes that life science and healthcare technologies will deliver transformative treatments for patients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -22.2 | |||||
| 3-Year FCF Growth Rate | 21.2 | |||||
| 3-Year Book Growth Rate | 20.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 100 | |||||
| 12-1 Month Momentum % | 17.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 62.6 | |||||
| Quick Ratio | 62.6 | |||||
| Cash Ratio | 62.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 20.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -0.78 | |||||
| ROA % | -0.74 | |||||
| ROIC % | -2.41 | |||||
| 3-Year ROIIC % | 3.89 | |||||
| ROC (Joel Greenblatt) % | -800 | |||||
| ROCE % | -0.82 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.01 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| EV-to-EBIT | -110.38 | |||||
| EV-to-EBITDA | 441.53 | |||||
| EV-to-FCF | -101.89 | |||||
| Price-to-Projected-FCF | 2.2 | |||||
| Price-to-Net-Current-Asset-Value | 3.4 | |||||
| Price-to-Net-Cash | 3.44 | |||||
| Earnings Yield (Greenblatt) % | -0.91 | |||||
| FCF Yield % | -0.67 | |||||
| Forward Rate of Return (Yacktman) % | -39.21 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers